Hereditary hemorrhagic telangiectasia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Overall, our results indicate that the BMP9/ALK1 hub critically mediates vascular quiescence by limiting PI3K signaling and suggest that PI3K inhibitors could be used as novel therapeutic agents to treat hereditary hemorrhagic telangiectasia.
|
29449337 |
2018 |
Hereditary hemorrhagic telangiectasia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia.
|
28796572 |
2017 |
Hereditary hemorrhagic telangiectasia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Finally, tacrolimus stimulated Smad1/5/8 signaling in C2C12 cells expressing BMP9-unresponsive ALK1 HHT mutants and in HHT patient blood outgrowth ECs.
|
28973643 |
2017 |
Hereditary hemorrhagic telangiectasia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Arteriovenous malformations in hereditary haemorrhagic telangiectasia: looking beyond ALK1-NOTCH interactions.
|
26645978 |
2016 |
Hereditary hemorrhagic telangiectasia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Although mutations in ALK1, a member of the transforming growth factor (TGF)-β/bone morphogenetic protein (BMP) receptor family, have been linked to hereditary hemorrhagic telangiectasia, a human vascular disease, the roles of activin receptor-like kinase 1 (ALK-1) signals in LV formation largely remain to be elucidated.
|
24133138 |
2013 |
Hereditary hemorrhagic telangiectasia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Among them, the identification of bone morphogenetic protein receptor type 2 (BMPR2) as the major predisposing gene and activin A receptor type II-like kinase-1 (ACVRL1, also known as ALK1) as the major gene when PAH is associated with hereditary hemorrhagic telangiectasia.
|
24355637 |
2013 |
Hereditary hemorrhagic telangiectasia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Retention in the endoplasmic reticulum is the underlying mechanism of some hereditary haemorrhagic telangiectasia type 2 ALK1 missense mutations.
|
23124896 |
2013 |
Hereditary hemorrhagic telangiectasia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Familial cases have long been recognised and are usually due to mutations in the bone morphogenetic protein receptor type 2 gene (BMPR2), or, much less commonly, two other members of the transforming growth factor-β superfamily, activin-like kinase-type 1 (ALK1), and endoglin (ENG), which are associated with hereditary hemorrhagic telangiectasia.
|
23733703 |
2011 |
Hereditary hemorrhagic telangiectasia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Clinical features of pulmonary arterial hypertension in young people with an ALK1 mutation and hereditary haemorrhagic telangiectasia.
|
19357124 |
2009 |
Hereditary hemorrhagic telangiectasia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Patients with hereditary hemorrhagic telangiectasia genotype ALK-1 (HHT2-ALK-1) with nonsense mutation demonstrated tendentially higher health-related quality of life (HR-QOL) scores than patients with HHT with genotype ENG (HHT1-ENG) with missense mutation.
|
18855162 |
2009 |
Hereditary hemorrhagic telangiectasia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Familial cases have long been recognized and are usually due to mutations in the bone morphogenetic protein receptor type 2 gene (BMPR2), or, much less commonly, 2 other members of the transforming growth factor-beta superfamily, activin-like kinase-type 1 (ALK1) and endoglin (ENG), which are associated with hereditary hemorrhagic telangiectasia.
|
19555857 |
2009 |
Hereditary hemorrhagic telangiectasia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
To our knowledge, this is the first report on whole ALK1 gene deletions in HHT patients.
|
18312453 |
2008 |
Hereditary hemorrhagic telangiectasia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers.
|
17388964 |
2007 |
Hereditary hemorrhagic telangiectasia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Endoglin and ALK1 mutations are thought to affect endothelial cell metabolism, angiogenesis and vascular remodelling, even if the precise mechanism leading to the HHT lesions is still obscure.
|
18220803 |
2007 |
Hereditary hemorrhagic telangiectasia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutation analysis in hereditary haemorrhagic telangiectasia in Germany reveals 11 novel ENG and 12 novel ACVRL1/ALK1 mutations.
|
16542389 |
2006 |
Hereditary hemorrhagic telangiectasia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Functional analysis of mutations in the kinase domain of the TGF-beta receptor ALK1 reveals different mechanisms for induction of hereditary hemorrhagic telangiectasia.
|
16282348 |
2006 |
Hereditary hemorrhagic telangiectasia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
These findings indicate that the mutation causes truncation of the ALK-1 protein at the post-transcriptional level; the plasma thrombomodulin may provide an easy diagnostic indicator in HHT patients.
|
16861286 |
2006 |
Hereditary hemorrhagic telangiectasia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Defective TGF-beta signaling in endothelial cells attributable to mutations in endoglin or the type I receptor ALK-1 leads to hereditary hemorrhagic telangiectasia, whereas defective BMP signaling attributable to mutations in the BMP receptor II has been associated with development of primary pulmonary hypertension.
|
16675726 |
2006 |
Hereditary hemorrhagic telangiectasia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia and expression analysis of Endoglin and ALK1.
|
16470589 |
2006 |
Hereditary hemorrhagic telangiectasia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Mutations in the gene that codes for activin receptor-like kinase (ALK 1), another transforming growth factor beta (TGF-beta) cell surface receptor, appear responsible for the rare occurrence of pulmonary arterial hypertension in patients with hereditary hemorrhagic telangiectasia.
|
16121312 |
2005 |
Hereditary hemorrhagic telangiectasia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Hepatic manifestation is associated with ALK1 in hereditary hemorrhagic telangiectasia: identification of five novel ALK1 and one novel ENG mutations.
|
15712270 |
2005 |
Hereditary hemorrhagic telangiectasia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Exonic mutations in BMPR2 are found in about 50% of patients with familial PAH, and ALK1 mutations are found in a minority of patients with hereditary hemorrhagic telangiectasia and co-existent PAH.
|
15194176 |
2004 |
Hereditary hemorrhagic telangiectasia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the endoglin (ENG) or ALK1 genes are responsible for hereditary hemorrhagic telangiectasia types 1 and 2 (HHT1 and HHT2), respectively, a dominant vascular dysplasia caused by haploinsufficiency.
|
15375013 |
2004 |
Hereditary hemorrhagic telangiectasia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Clinical phenotypes, ALK1 gene mutation and level of related plasma proteins in Chinese hereditary hemorrhagic telangiectasia.
|
15198877 |
2004 |
Hereditary hemorrhagic telangiectasia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in France.
|
15024723 |
2004 |